Back to top

Jazz Pharmaceuticals plc Enters Oversold Territory

Read MoreHide Full Article

Jazz Pharmaceuticals plc’s (JAZZ - Free Report) share price has entered into oversold territory with a stochastic value of 18.3129. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 12 cents over the past month to $4.41 per share. Jazz Pharmaceuticals plc is a Zacks #2 Rank (“Buy”) company.


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Jazz Pharmaceuticals PLC (JAZZ) - free report >>

More from Zacks Tale of the Tape

You May Like